Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Immune response to vaccine adjuvants during the first year of life.

Levy O, Goriely S, Kollmann TR.

Vaccine. 2013 May 17;31(21):2500-5. doi: 10.1016/j.vaccine.2012.10.016. Epub 2012 Oct 18. Review.

2.

Immunopathology of RSV infection: prospects for developing vaccines without this complication.

van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J.

Rev Med Virol. 2007 Jan-Feb;17(1):5-34. Review.

PMID:
17004293
3.

The search for novel adjuvants for early life vaccinations: can "danger" motifs show us the way?

Kovarik J, Siegrist CA.

Arch Immunol Ther Exp (Warsz). 2001;49(3):209-15. Review.

PMID:
11478395
4.

Targeting the innate immune response with improved vaccine adjuvants.

Pashine A, Valiante NM, Ulmer JB.

Nat Med. 2005 Apr;11(4 Suppl):S63-8. Review.

PMID:
15812492
5.

Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.

Marciani DJ.

Drug Discov Today. 2003 Oct 15;8(20):934-43. Review.

PMID:
14554157
6.

Vaccine adjuvants: putting innate immunity to work.

Coffman RL, Sher A, Seder RA.

Immunity. 2010 Oct 29;33(4):492-503. doi: 10.1016/j.immuni.2010.10.002. Review.

7.

Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.

Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW.

Int J Pharm. 2008 Dec 8;364(2):272-80. doi: 10.1016/j.ijpharm.2008.04.036. Epub 2008 Apr 30. Review.

PMID:
18555624
8.

Adjuvants for veterinary vaccines--types and modes of action.

Gerdts V.

Berl Munch Tierarztl Wochenschr. 2015 Nov-Dec;128(11-12):456-63. Review.

PMID:
26697712
9.

Enhancement of vaccine potency through improved delivery.

Ulmer JB.

Expert Opin Biol Ther. 2004 Jul;4(7):1045-51. Review.

PMID:
15268672
10.

Targeting Syk-Card9-activating C-type lectin receptors by vaccine adjuvants: findings, implications and open questions.

Lang R, Schoenen H, Desel C.

Immunobiology. 2011 Nov;216(11):1184-91. doi: 10.1016/j.imbio.2011.06.005. Epub 2011 Jun 21. Review.

PMID:
21742403
11.

The global impact of vaccines containing aluminium adjuvants.

Clements CJ, Griffiths E.

Vaccine. 2002 May 31;20 Suppl 3:S24-33. Review.

PMID:
12184361
12.

Unmet needs in modern vaccinology: adjuvants to improve the immune response.

Leroux-Roels G.

Vaccine. 2010 Aug 31;28 Suppl 3:C25-36. doi: 10.1016/j.vaccine.2010.07.021. Review.

PMID:
20713254
13.

MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile.

Podda A, Del Giudice G.

Expert Rev Vaccines. 2003 Apr;2(2):197-203. Review.

PMID:
12899571
14.

Synthetic vaccines: the role of adjuvants in immune targeting.

Jiang ZH, Koganty RR.

Curr Med Chem. 2003 Aug;10(15):1423-39. Review.

PMID:
12871139
15.

Adjuvants for human vaccines--current status, problems and future prospects.

Gupta RK, Siber GR.

Vaccine. 1995 Oct;13(14):1263-76. Review.

PMID:
8585280
16.

Factors influencing innate immunity and vaccine responses in infancy.

Kampmann B, Jones CE.

Philos Trans R Soc Lond B Biol Sci. 2015 Jun 19;370(1671). pii: 20140148. doi: 10.1098/rstb.2014.0148. Review.

PMID:
25964459
17.

Adjuvants in veterinary vaccines: modes of action and adverse effects.

Spickler AR, Roth JA.

J Vet Intern Med. 2003 May-Jun;17(3):273-81. Review.

18.

The role of adjuvants in retroviral vaccines.

Vogel FR.

Int J Immunopharmacol. 1995 Feb;17(2):85-90. Review.

PMID:
7657411
19.

Vaccine adjuvants: current challenges and future approaches.

Wilson-Welder JH, Torres MP, Kipper MJ, Mallapragada SK, Wannemuehler MJ, Narasimhan B.

J Pharm Sci. 2009 Apr;98(4):1278-316. doi: 10.1002/jps.21523. Review.

PMID:
18704954
20.

[The importance of the second generation adjuvanted systems in "new" vaccines].

Beran J.

Klin Mikrobiol Infekc Lek. 2008 Feb;14(1):5-12. Review. Czech.

PMID:
18327735
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk